EBITDA Growth
7.37%
Quarterly · Period ending:
MRNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported7.37%period ending
Latest reported7.37%period ending
MRNA Quarterly EBITDA YoY % (10.50% → 7.37%)
Year-over-year change
High-resolution chart · PNG
MRNA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 7.3684% | |
| -36.1472% | |
| 34.5259% | |
| -270.8861% | |
| 38.3117% | |
| 17.7204% | |
| -502.1583% | |
| 104.6498% | |
| 25.0608% | |
| -415.1376% | |
| -84.0688% | |
| -226.9806% | |
| -164.3444% | |
| -105.0627% | |
| -68.2034% | |
| -63.0998% | |
| -18.5528% | |
| 236.9327% | |
| 2,212.4104% | |
| 1,737.4787% | |
| 3,040.377% | |
| 1,210.831% | |
| -128.9473% | |
| -93.3467% | |
| 15.5536% | |
| 7.0837% | |
| 14.2828% | |
| -55.0833% | |
| -49.3486% | |
| -84.2669% | |
| -268.6214% | |
| -17.708% | |
| -12.6647% | |
| 10.5044% |